Table 4 Risk of T2DM with HTN according to baseline TyG in unadjusted and adjusted models in all subjects with LCL-C < 2.6 mmol/L or HDL-C > 1.0 mmol/L

All subjects

HDL-C > 1.0 mmol/L

TyG in transform Q4

Q1

1

1

1

Q2

2.193(0.894–4.379) 0.075

1.762(0.801–4.241) 0.078

2.223(0.894–5.009) 0.069

Q3

1.562(0.590–3.223) 0.736

1.344(0.520–2.872) 0.676

1.290(0.369–2.901) 0.729

Q4

3.751(1.442–6.374) 0.003*

2.371(1.845–6.326) 0.005*

2.809(1.354–6.111) 0.021*

LDL-C < 2.6 mmol/L

TyG in transform Q4

Q1

1

1

1

Q2

2.223(0.893–4.221) 0.059

2.053(0.953–4.469) 0.085

2.129(0.879–4.156) 0.069

Q3

1.529(0.346–3.469) 0.307

1.512(0.580–3.273) 0.542

1.109(0.389–2.815) 0.815

Q4

3.414(1.582–7.733) 0.001*

3.818(1.538–7.029) 0.002*

2.907(1.223–6.309) 0.019*